ZELDIN Act
- Sponsor
- Rep. Carter, Troy A. [D-LA-2]
- Committees
- Rules Committee (primary)
- Last action
- Apr 22, 2026
Bottom line
The ZELDIN Act aims to increase congressional oversight and internal accountability for the EPA's legal enforcement actions and grant management, particularly regarding carcinogen-related claims and regulatory analysis.
What it actually does
This bill, known as the ZELDIN Act, requires the Administrator of the Environmental Protection Agency (EPA) to obtain congressional approval before dismissing lawsuits or withdrawing referrals to the Department of Justice (DOJ) concerning claims related to the release of known or likely human carcinogens. It also mandates that the EPA Administrator consult with the Office of General Counsel before terminating grants and codifies specific economic analysis guidelines for EPA rulemaking. Furthermore, it establishes judicial relief and penalties for violations of these new requirements.
Proponents argue
Proponents argue that the bill enhances accountability and transparency within the EPA, preventing politically motivated dismissals of critical environmental lawsuits and ensuring proper stewardship of federal grants. They contend that requiring congressional approval for actions involving carcinogens protects public health by ensuring robust enforcement, and that codifying regulatory analysis standards promotes sound, evidence-based policymaking.
Opponents contend
Opponents might argue that the bill could politicize environmental enforcement decisions, creating bureaucratic hurdles that delay or hinder the EPA's ability to swiftly address public health threats. They may contend that it infringes upon the executive branch's authority and operational efficiency, potentially leading to less effective environmental protection if congressional action is slow or divided.
The bill is relatively short and its core provisions are accessible, though the detailed procedural rules for congressional action require careful reading.
Section 2
Congressional Approval for Dismissal of Carcinogen Lawsuits
This section mandates that the EPA Administrator must seek and receive congressional approval via a joint resolution before dismissing any lawsuit or withdrawing any referral to the Department of Justice related to a 'covered claim.' A covered claim is defined as one where a person is accused of releasing a chemical determined by EPA's Integrated Risk Information System (IRIS) assessment to be a likely or known human carcinogen. The bill outlines expedited procedures for Congress to consider and vote on such a joint resolution of approval.
Supporters argue
Supporters argue that this provision ensures greater accountability for EPA's enforcement decisions, particularly when public health is at stake due to carcinogen exposure. They contend it prevents the executive branch from unilaterally abandoning critical environmental cases, thereby safeguarding communities and the environment.
Critics contend
Critics might argue that this provision politicizes scientific and legal enforcement decisions, potentially delaying crucial actions against polluters. They may contend it creates an unnecessary bureaucratic hurdle that could undermine the EPA's ability to effectively protect public health and the environment.
Tradeoffs
This provision balances executive branch discretion in legal enforcement against congressional oversight and accountability. It trades potential for faster executive action for increased transparency and political review in sensitive environmental cases.
Section 3
Consultation Prior to Termination of Grants
This section requires the EPA Administrator to consult with the EPA's Office of General Counsel (OGC) to determine if terminating any grant or cooperative agreement complies with existing rules, regulations, and the terms of the agreement. The Administrator is prohibited from terminating a grant or agreement unless the OGC determines that such termination is in compliance with these standards.
Section 4
Preservation of Obligations of Grants and Cooperative Agreements
This section prohibits the untimely deobligation of funds awarded through EPA grants or cooperative agreements. Specifically, funds cannot be deemed unobligated or returned to the Treasury upon termination of an agreement until all civil actions (pending or filed after enactment) and administrative processes related to those funds have been completed. It also prevents federal agencies from considering a recipient's failure to close out a grant during the pendency of a judicial proceeding contesting its termination when evaluating future grant applications or in federal reporting systems.
Sections 5 and 6
Judicial Relief and Penalty for Violations
Section 5 allows any person harmed by a violation of this Act to bring a civil action against the EPA Administrator in federal district court, seeking injunctive relief, damages (compensatory, punitive, or $1,000 per violation, or triple that amount for bad faith violations), and attorney's fees. Section 6 specifies that if a court finds the Administrator violated Section 2 (congressional approval) or Section 3 (grant consultation), the court may reduce the Administrator's annual basic pay to $1.
Section 7
Codification of EPA Rulemaking Processes
This section directs the EPA Administrator to implement specific regulatory analysis guidance for 'significant regulatory actions' (as defined by Executive Order 12866). Specifically, the EPA must follow Circular No. A-4 issued by the Office of Management and Budget (OMB) in 2023 for significant regulatory actions, including those quantifying public health benefits. Additionally, all economic analyses prepared by the EPA must adhere to the 'Guidelines for Preparing Economic Analyses (3rd edition)' issued by the EPA itself in 2024.
Section 8
Sunset Clause
This section states that the entire Act shall sunset, or expire, on January 20, 2029.
The definition of 'covered claim' limits the congressional approval requirement to claims involving chemicals that the EPA has determined, through an Integrated Risk Information System (IRIS) assessment, to be a 'likely or known human carcinogen.'
Section 2(d)(1)
Why it matters:This is standard legislative practice to define terms, but its placement in a definitions subsection could lead a reader to miss the specific criteria that trigger congressional oversight.
Case for: Supporters would argue that this precise definition ensures that congressional oversight is triggered only for the most serious public health threats, where scientific consensus on carcinogenicity is established, preventing overreach into less certain cases.
Case against: Critics might argue that by tying oversight to a specific EPA assessment system (IRIS), the bill could inadvertently limit its scope if EPA uses other assessment methods or if the IRIS process itself becomes subject to political influence or delays.
Estimated impact: This definition significantly narrows the range of EPA legal actions that would require congressional approval, focusing the bill's impact on a specific subset of environmental enforcement cases.
This subsection details highly specific and expedited procedural rules for how a 'joint resolution of approval' will be considered in both the House of Representatives and the Senate. It sets strict deadlines for committee reporting (3 legislative/session days), limits debate (2 hours), waives points of order, and prohibits amendments, ensuring a swift up-or-down vote.
Section 2(c)
Why it matters:These are standard 'fast-track' legislative procedures, often included to ensure that Congress can act quickly on specific matters. While technically complex, their inclusion is a deliberate design choice to make the bill's approval mechanism functional.
Case for: Proponents would argue that these expedited procedures are essential to make the congressional approval mechanism workable. Without them, the process could be endlessly delayed by procedural maneuvers, rendering the oversight requirement ineffective.
Case against: Critics might argue that these fast-track procedures limit thorough debate and amendment, potentially forcing Congress to make quick decisions on complex environmental enforcement matters without adequate deliberation or the ability to refine the resolution.
Estimated impact: These procedural rules are critical to the bill's enforceability, determining whether Congress can realistically exercise the oversight power granted in Section 2(a). They significantly impact the speed and nature of congressional response.